Trustar Capital completed the acquisition of Guilong Pharmaceutical.

Synopsis

Trustar Capital, a private equity affiliate of CITIC, completed the acquisition of Guilong Pharmaceutical, a company that manufactures and distributes pharmaceutical products. Financial terms were not disclosed. Founded in 1989, Guilong Pharmaceutical offers OTC medicines for sore throat and other throat-related ailments.

Principals

target

Guilong Pharmaceutical

bidder

Trustar Capital (ex Citic Capital Partners)

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context